Study record managers: refer to the Data Element Definitions if submitting registration or results information.
|1||NCT03536780||Recruiting||Avelumab in Combination With Gemcitabine in Advanced Leiomyosarcoma as a Second-line Treatment||
||Other / Industry||
||38||All||20 Years and older (Adult, Older Adult)||NCT03536780||KCSG UN18-06
|EAGLES||October 1, 2018||September 30, 2021||February 28, 2022||May 25, 2018||February 15, 2019||